These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29082769)

  • 1. How efficient are rodent models for Alzheimer's disease drug discovery?
    Guo B; Zhou Q
    Expert Opin Drug Discov; 2018 Feb; 13(2):113-115. PubMed ID: 29082769
    [No Abstract]   [Full Text] [Related]  

  • 2. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 3. Rodent models for Alzheimer's disease drug discovery.
    Puzzo D; Gulisano W; Palmeri A; Arancio O
    Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can cloud-based tools accelerate Alzheimer's disease drug discovery?
    Cacabelos R; Teijido O; Carril JC
    Expert Opin Drug Discov; 2016; 11(3):215-23. PubMed ID: 26766514
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.
    Hodes RJ; Buckholtz N
    Expert Opin Ther Targets; 2016; 20(4):389-91. PubMed ID: 26853544
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug discovery, development and delivery in Alzheimer's disease.
    Brambilla D
    Pharm Res; 2017 Dec; 35(1):3. PubMed ID: 29288429
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease in the zebrafish: where can we take it?
    Caramillo EM; Echevarria DJ
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):179-186. PubMed ID: 28177980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
    Franco R; Martínez-Pinilla E; Navarro G
    Expert Opin Drug Discov; 2019 Apr; 14(4):327-330. PubMed ID: 30775940
    [No Abstract]   [Full Text] [Related]  

  • 11. Non human primate models for Alzheimer's disease-related research and drug discovery.
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2017 Feb; 12(2):187-200. PubMed ID: 27960560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models in the drug discovery pipeline for Alzheimer's disease.
    Van Dam D; De Deyn PP
    Br J Pharmacol; 2011 Oct; 164(4):1285-300. PubMed ID: 21371009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
    Ising C; Stanley M; Holtzman DM
    Clin Pharmacol Ther; 2015 Nov; 98(5):469-71. PubMed ID: 26250900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considering a new paradigm for Alzheimer's disease research.
    Langley GR
    Drug Discov Today; 2014 Aug; 19(8):1114-24. PubMed ID: 24662035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative approach to drug discovery for Alzheimer's disease dementia.
    Schubert D; Maher P
    Future Med Chem; 2012 Sep; 4(13):1681-8. PubMed ID: 22924506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery in dementia: the role of rodent models.
    Van Dam D; De Deyn PP
    Nat Rev Drug Discov; 2006 Nov; 5(11):956-70. PubMed ID: 17080031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story.
    Stamford A; Strickland C
    Curr Opin Chem Biol; 2013 Jun; 17(3):320-8. PubMed ID: 23683349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of mice and men: bridging the translational disconnect in CNS drug discovery.
    Geerts H
    CNS Drugs; 2009 Nov; 23(11):915-26. PubMed ID: 19845413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.